Novavax Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Novavax Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- NVAX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001000694
Board of directors
-
David M. Mott · DirectorSince 2023
-
Gregg H. Alton · DirectorSince 2023
-
James F. Young · DirectorSince 2023
-
John C. Jacobs · Director · President and CEOSince 2023
-
John W. Shiver · DirectorSince 2025
-
Margaret G. Mcglynn · DirectorSince 2023
-
Rachel K. King · DirectorSince 2023
-
Richard Douglas · DirectorSince 2023
-
Richard J. Rodgers · DirectorSince 2023
Chief executives
John C. Jacobs
· President and CEO
Since January 2023
Board connections
6 of this board's directors also sit on 10 other boards.
- via David M. Mott and Richard J. Rodgers
- via Richard Douglas
- via Gregg H. Alton
- via Rachel K. King
- via Rachel K. King
- via Gregg H. Alton
- via Richard Douglas
- via Richard J. Rodgers
- via Richard J. Rodgers
- via Margaret G. Mcglynn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2024 | Casey Mark J Officer (EVP, Chief Legal Officer) | Option exercise | +41,900 | — | — |
| Dec 11, 2024 | Casey Mark J Officer (EVP, Chief Legal Officer) | Shares withheld for tax | −12,713 | $8.82 | $112,129 |
| Aug 19, 2024 | Trizzino John Officer (EVP, CCO and CBO) | Option exercise | +655 | — | — |
| Aug 19, 2024 | Trizzino John Officer (EVP, CCO and CBO) | Shares withheld for tax | −317 | $13.90 | $4,406 |
| Aug 16, 2024 | Kelly James Patrick Officer (EVP, CFO and Treasurer) | Option exercise | +2,367 | $12.96 | $30,676 |
| Aug 16, 2024 | Kelly James Patrick Officer (EVP, CFO and Treasurer) | Shares withheld for tax | −1,223 | $12.96 | $15,850 |
| Jun 21, 2024 | James F. Young Director | Open-market sale | −7,500 | $14.09 | $105,675 |
| Jun 18, 2024 | James F. Young Director | Open-market sale | −6,393 | $13.62 | $87,073 |
| Jun 18, 2024 | James F. Young Director | Open-market sale | −1,107 | $14.28 | $15,808 |
| Jun 17, 2024 | Dubovsky Filip Officer (President, R&D) | Option exercise | +1,404 | $6.97 | $9,786 |
| Jun 17, 2024 | Dubovsky Filip Officer (President, R&D) | Option exercise | +12,500 | $6.09 | $76,125 |
| Jun 17, 2024 | Dubovsky Filip Officer (President, R&D) | Open-market sale | −12,500 | $14.46 | $180,750 |
| Jun 17, 2024 | Dubovsky Filip Officer (President, R&D) | Open-market sale | −1,404 | $14.54 | $20,414 |
| Jun 12, 2024 | Margaret G. Mcglynn Director | Option exercise | +6,670 | — | — |
| Jun 12, 2024 | Gregg H. Alton Director | Option exercise | +6,670 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.